Upchurch G R, Ford J W, Weiss S J, Knipp B S, Peterson D A, Thompson R W, Eagleton M J, Broady A J, Proctor M C, Stanley J C
Jobst Vascular Research Laboratories, Section of Vascular Surgery, Department of Surgery, University of Michigan Medical School, USA.
J Vasc Surg. 2001 Jul;34(1):76-83. doi: 10.1067/mva.2001.115598.
The hypothesis to be tested was that diminished bioavailable nitric oxide (NO) affects matrix metalloproteinase (MMP) expression and activation in vascular smooth muscle cells (SMCs).
Cultivated rat aortic SMCs (RA-SMCs) were exposed to increasing concentrations of L-N-monomethyl arginine (L-NMMA), a nonselective inhibitor of NO synthase, in the presence of proinflammatory cytokines (50 ng/mL interleukin [IL]-1beta, 50 ng/mL interferon-gamma, and 30 microg/mL lipopolysaccharide). Nitrite and nitrate, two of the final end products of NO metabolism, were measured in media collected at 48 hours with the use of the Saville assay (n = 4). MMP activity was measured with 1% gelatin zymography (n = 4). In separate experiments in which 2 ng/mL of IL-1beta and L-NMMA was used, MMP protein and messenger RNA (mRNA) levels were determined with Western blot analysis (n = 3) and semiquantitative reverse transcriptase-polymerase chain reaction (n = 3), respectively. Data were analyzed with nonparametric analysis of variance.
Increasing concentrations of the NO synthase inhibitor L-NMMA caused a dose-dependent decrease (P <.05) in nitrite and nitrate production by RA-SMCs after cytokine exposure. Zymography documented an early dosedependent increase (P <.05 compared with cytokines alone) in 92-kd MMP activity, with no significant changes in 72-kd MMP activity after treatment with L-NMMA (P >.05 compared with cytokines alone). Reverse transcriptase-polymerase chain reaction and Western blot analysis revealed that the addition of L-NMMA to IL-1beta-stimulated RA-SMCs led to significant increases in MMP-9 mRNA (n = 3, P <.01 for 1.0 mmol/L L-NMMA) and MMP-9 protein levels (n = 3, P <.05), respectively. No differences in MMP-2 mRNA or protein levels were demonstrated.
Inhibition of cytokine-induced NO expression in RA-SMCs is associated with a selective, dose-dependent increase in MMP-9 expression and synthesis. These findings suggest that alterations in local NO synthesis may influence MMP-9-dependent vessel wall damage.
待检验的假设是生物可利用的一氧化氮(NO)减少会影响血管平滑肌细胞(SMC)中基质金属蛋白酶(MMP)的表达和激活。
在存在促炎细胞因子(50 ng/mL白细胞介素[IL]-1β、50 ng/mL干扰素-γ和30 μg/mL脂多糖)的情况下,将培养的大鼠主动脉SMC(RA-SMC)暴露于浓度递增的L-N-单甲基精氨酸(L-NMMA,一种NO合酶的非选择性抑制剂)中。使用萨维尔分析法(n = 4)测定在48小时收集的培养基中亚硝酸盐和硝酸盐(NO代谢的两种最终终产物)。用1%明胶酶谱法测定MMP活性(n = 4)。在使用2 ng/mL IL-1β和L-NMMA的单独实验中,分别用蛋白质印迹分析(n = 3)和半定量逆转录聚合酶链反应(n = 3)测定MMP蛋白和信使核糖核酸(mRNA)水平。数据采用非参数方差分析。
细胞因子暴露后,NO合酶抑制剂L-NMMA浓度增加导致RA-SMC产生的亚硝酸盐和硝酸盐呈剂量依赖性减少(P <.05)。酶谱分析表明,92-kd MMP活性早期呈剂量依赖性增加(与单独使用细胞因子相比,P <.05),而用L-NMMA处理后72-kd MMP活性无显著变化(与单独使用细胞因子相比,P >.05)。逆转录聚合酶链反应和蛋白质印迹分析显示,向IL-1β刺激的RA-SMC中添加L-NMMA分别导致MMP-9 mRNA(n = 3,1.0 mmol/L L-NMMA时P <.01)和MMP-9蛋白水平(n = 3,P <.05)显著增加。未显示MMP-2 mRNA或蛋白水平有差异。
RA-SMC中细胞因子诱导的NO表达受抑制与MMP-9表达和合成的选择性、剂量依赖性增加有关。这些发现表明局部NO合成的改变可能影响依赖MMP-9的血管壁损伤。